To understand the cytotoxic effect of Melatonin on HER2+ breast cancer cells, we recently performed transcriptome profiling of the HCC1954 cells treated with or without Melatonin by RNA sequencing (RNA-Seq, GSE175906). The gene discussed is ERBB2; the disease is breast carcinoma.